Skip to Main Content
Back to News

Fund Update: Perpetual Ltd added 867,446 shares of NUTANIX ($NTNX) to their portfolio

None

Perpetual Ltd has added 867,446 shares of $NTNX to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $NTNX.

NUTANIX Hedge Fund Activity

We have seen 307 institutional investors add shares of NUTANIX stock to their portfolio, and 207 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NUTANIX Insider Trading Activity

NUTANIX insiders have traded $NTNX stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $NTNX stock by insiders over the last 6 months:

  • GROEN MAX PIETER DE sold 5,500,000 shares for an estimated $409,805,000
  • RAJIV RAMASWAMI (President and CEO) has made 0 purchases and 4 sales selling 167,493 shares for an estimated $11,498,166.
  • RUKMINI SIVARAMAN (Chief Financial Officer) has made 0 purchases and 5 sales selling 14,625 shares for an estimated $981,671.
  • STEVEN J GOMO sold 7,000 shares for an estimated $533,146
  • VIRGINIA GAMBALE sold 6,060 shares for an estimated $392,278

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NUTANIX Congressional Stock Trading

Members of Congress have traded $NTNX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NTNX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NUTANIX Analyst Ratings

Wall Street analysts have issued reports on $NTNX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • RBC Capital issued a "Outperform" rating on 03/02/2025
  • Barclays issued a "Overweight" rating on 02/27/2025
  • Piper Sandler issued a "Overweight" rating on 11/27/2024
  • Morgan Stanley issued a "Overweight" rating on 10/28/2024
  • Wolfe Research issued a "Outperform" rating on 10/28/2024

To track analyst ratings and price targets for NUTANIX, check out Quiver Quantitative's $NTNX forecast page.

NUTANIX Price Targets

Multiple analysts have issued price targets for $NTNX recently. We have seen 4 analysts offer price targets for $NTNX in the last 6 months, with a median target of $83.0.

Here are some recent targets:

  • An analyst from Barclays set a target price of $94.0 on 02/27/2025
  • An analyst from Raymond James set a target price of $83.0 on 02/27/2025
  • James Fish from Piper Sandler set a target price of $83.0 on 11/27/2024
  • Meta Marshall from Morgan Stanley set a target price of $72.0 on 10/28/2024

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $NTNX ticker page for more data.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles